Mary Nyberg
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Multiple Sclerosis Research Studies, Herpesvirus Infections and Treatments, Statistical Methods in Clinical Trials
Most-Cited Works
- → Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone(2015)24 cited
- → A Comparison of the Safety/Tolerability and Pharmacodynamics of ActharGel and Methylprednisolone with Regimens Utilized for the Treatment of MS Exacerbations (P2.207)(2014)1 cited
- → Abstract CT103: Next generation capecitabine (NGC-Cap) in phase 1b trial significantly increases 5-FU exposure while improving safety profile compared to capecitabine(2024)
- → Safety and efficacy of eniluracil + capecitabine (6422 + Cap) in phase 1b trial.(2025)
- → Preclinical Project Optimus dose escalation of SN-38 pro-drug PCS11T.(2025)
- → Evaluation of potential instruments for quantifying necrobiosis lipoidica severity via physician evaluation and patient-reported outcomes(2023)
- → Abstract LB278: Application of phase 1 and pre-clinical data to assist in determining the optimal dosage regimen for cancer drugs using the principles of Project Optimus(2024)
- → Adaptive designed eniluracil + capecitabine phase 2 trial in advanced or metastatic breast cancer patients.(2025)